Addiction. 2002 Sep;97(9):1183-94. doi: 10.1046/j.1360-0443.2002.00185.x.
The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was developed for the World Health Organization (WHO) by an international group of substance abuse researchers to detect psychoactive substance use and related problems in primary care patients. This report describes the new instrument as well as a study of its reliability and feasibility.
The study was conducted at participating sites in Australia, Brazil, Ireland, India, Israel, the Palestinian Territories, Puerto Rico, the United Kingdom and Zimbabwe. Sixty per cent of the sample was recruited from alcohol and drug abuse treatment facilities; the remainder was drawn from general medical settings and psychiatric facilities.
The study was concerned primarily with test item reliability, using a simple test-retest procedure to determine whether subjects would respond consistently to the same items when presented in an interview format on two different occasions. Qualitative and quantitative data were also collected to evaluate the feasibility of the screening items and rating format.
A total of 236 volunteer participants completed test and retest interviews at nine collaborating sites. Slightly over half of the sample (53.6%) was male. The mean age of the sample was 34 years and they had completed, on average, 10 years of education.
The average test-retest reliability coefficients (kappas) ranged from a high of 0.90 (consistency of reporting 'ever' use of substance) to a low of 0.58 (regretted what was done under influence of substance). The average kappas for substance classes ranged from 0.61 for sedatives to 0.78 for opioids. In general, the reliabilities were in the range of good to excellent, with the following items demonstrating the highest kappas across all drug classes: use in the last 3 months, preoccupied with drug use, concern expressed by others, troubled by problems related to drug use, intravenous drug use. Qualitative data collected at the end of the retest interview suggested that the questions were not difficult to answer and were consistent with patients' expectations for a health interview. The data were used to guide the selection of a smaller set of items that can serve as the basis for more extensive validation research.
The ASSIST items are reliable and feasible to use as part of an international screening test. Further evaluation of the screening test should be conducted.
酒精、吸烟与物质使用筛查测试（ASSIST）由一个国际药物滥用研究小组为世界卫生组织（WHO）研发，用于检测初级保健患者中的精神活性物质使用情况及相关问题。本报告介绍了这一新工具及其可靠性和可行性研究。
该研究在澳大利亚、巴西、爱尔兰、印度、以色列、巴勒斯坦地区、波多黎各、英国和津巴布韦的参与站点进行。60%的样本来自酒精和药物滥用治疗机构；其余样本来自普通医疗场所和精神科设施。
该研究主要关注测试项目的可靠性，采用简单的重测程序来确定受试者在两次不同场合以访谈形式呈现相同项目时是否会给出一致的回答。还收集了定性和定量数据，以评估筛查项目和评分格式的可行性。
共有236名志愿者参与者在9个合作站点完成了测试和重测访谈。略超过一半的样本（53.6%）为男性。样本的平均年龄为34岁，平均接受了10年教育。
重测信度系数（kappa值）的平均值范围从高的0.90（报告“曾经”使用物质的一致性）到低的0.58（对在物质影响下所做之事感到后悔）。各类物质的平均kappa值范围从镇静剂的0.61到阿片类药物的0.78。总体而言，信度处于良好到优秀的范围内，以下项目在所有药物类别中显示出最高的kappa值：过去3个月内使用、沉迷于药物使用、他人表达的担忧、因与药物使用相关的问题而困扰、静脉注射药物使用。在重测访谈结束时收集的定性数据表明，这些问题不难回答，并且与患者对健康访谈的期望一致。这些数据被用于指导选择一组较小的项目，作为更广泛验证研究的基础。
ASSIST项目作为国际筛查测试的一部分使用是可靠且可行的。应进一步对该筛查测试进行评估。
